logo
  

U.S. Government To Acquire 10 Mln Treatment Courses Of COVID-19 Antiviral Candidate From Pfizer

Pfizer Inc. (PFE) has agreed to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID, to the U.S. government. The agreement is subject to regulatory authorization from the FDA. Currently, the company is seeking Emergency Use Authorization of PAXLOVID with the FDA.

The U.S. government will acquire 10 million treatment courses beginning later in the year and concluding in 2022. Pfizer will receive $5.29 billion from the government, pending and contingent upon regulatory authorization.

"We were thrilled with the recent results of our phase 2/3 interim analysis, which showed overwhelming efficacy of PAXLOVID in reducing the risk of hospitalization among high-risk patients treated within three days of symptom onset by almost 90% and with no deaths," said Albert Bourla, CEO, Pfizer.

Pfizer noted that it has also entered into advance purchase agreements with several other countries and has started bilateral outreach to approximately 100 countries.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Asweets Global Inc. is recalling about 2,000 units of Wonder & Wise Activity Tables for potential risk of choking hazard to young children, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the screws of the tables can become loose and/or detach from the xylophone component of the activity tables to pose a choking hazard to young children. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday a net loss for the fourth quarter that sharply widened from last year, despite 9 percent growth in revenues, hurt by a decreases in the market prices of our equity investments in publicly-traded companies. Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared...
Follow RTT